SeaStar Medical Holding Corporation (ICU) Insider Trading Activity
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
| $337M | ||
| $259M | ||
| $79M | ||
| $76M | ||
| $60M | ||
| $57M |
ICU Insider Trading Activity
ICU Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $165,943 | 6 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Neuman John | director | 4 | $153,227 | 0 | $0 | $153,227 |
| Chung Kevin | Chief Medical Officer | 2 | $12,716 | 0 | $0 | $12,716 |
About SeaStar Medical Holding Corporation
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Insider Activity of SeaStar Medical Holding Corporation
Over the last 12 months, insiders at SeaStar Medical Holding Corporation have bought $165,943 and sold $0 worth of SeaStar Medical Holding Corporation stock.
On average, over the past 5 years, insiders at SeaStar Medical Holding Corporation have bought $72,950 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Neuman John (director) — $153,227. Chung Kevin (Chief Medical Officer) — $12,716.
The last purchase of 10,000 shares for transaction amount of $20,405 was made by Neuman John (director) on 2024‑12‑11.
List of Insider Buy and Sell Transactions, SeaStar Medical Holding Corporation
| 2024-12-11 | Neuman John | director | 10,000 0.2126% | $2.04 | $20,405 | -15.31% | ||
| 2024-11-18 | Chung Kevin | Chief Medical Officer | 4,250 0.0842% | $1.99 | $8,458 | -18.22% | ||
| 2024-09-30 | Chung Kevin | Chief Medical Officer | 1,000 0.025% | $4.26 | $4,258 | -53.52% | ||
| 2024-08-15 | Neuman John | director | 10,000 0.1724% | $5.24 | $52,396 | -66.34% | ||
| 2024-06-17 | Neuman John | director | 10,000 0.3451% | $4.35 | $43,521 | -41.92% | ||
| 2024-06-14 | Neuman John | director | 10,000 0.2927% | $3.69 | $36,905 | -40.78% | ||
| 2023-11-22 | Van Heel Kenneth | director | 100,000 0.5274% | $0.40 | $40,000 | -2.62% | ||
| 2023-05-30 | Chung Kevin | Chief Medical Officer | 12,543 0.17% | $0.47 | $5,953 | -1.66% | ||
| 2022-04-05 | Chung Kevin | Chief Medical Officer | 3,760 0.1986% | $1.85 | $6,956 | +4209.11% |
Insider Historical Profitability
| Neuman John | director | 40000 0.408% | $50,800.00 | 4 | 0 | |
| Chung Kevin | Chief Medical Officer | 13685 0.1396% | $17,379.95 | 4 | 0 | <0.0001% |
| Van Heel Kenneth | director | 116400 1.1874% | $147,828.00 | 1 | 0 | <0.0001% |
Historical Insider Profitability vs. Competitors
$1,848,072 | 66 | -14.67% | $12.86M | |
$296,936 | 37 | -18.12% | $11.87M | |
$383,884 | 32 | -25.10% | $11.7M | |
$95,303,339 | 30 | -13.78% | $11.4M | |
$4,368,362 | 28 | -22.35% | $11.06M | |
$547,862 | 19 | -29.82% | $13.36M | |
$114,371,781 | 18 | -1.31% | $10.93M | |
$112,810,270 | 18 | -1.20% | $12.9M | |
$2,553,853 | 17 | 16.69% | $13.93M | |
$37,194,483 | 17 | -51.30% | $13.23M | |
$1,199,157 | 14 | 7.52% | $12.94M | |
$39,336,371 | 14 | -17.87% | $12.4M | |
$8,971,546 | 8 | 6.18% | $10.02M | |
$2,891,537 | 8 | -39.31% | $13.66M | |
$31,190 | 2 | -14.18% | $12.87M | |
SeaStar Medical Holding Corporation (ICU) | $45,953 | 2 | -2.14% | $12.45M |
$5,512,500 | 1 | -7.91% | $12.58M | |
$25,173 | 1 | -68.88% | $9.72M | |
$19,863 | 1 | 144.27% | $11.03M |
ICU Institutional Investors: Active Positions
| Increased Positions | 11 | +64.71% | 100,966 | +63.91% |
| Decreased Positions | 3 | -17.65% | 34,379 | -21.76% |
| New Positions | 7 | New | 89,783 | New |
| Sold Out Positions | 0 | Sold Out | 0 | Sold Out |
| Total Postitions | 25 | +47.06% | 224,562 | +42.15% |
ICU Ownership Change vs Market
Institutional Investor Ownership
| Vanguard Group Inc | $117.00 | 0.91% | 91,407 | +21,090 | +29.99% | 2024-12-31 |
| Geode Capital Management, Llc | $58.00 | 0.45% | 45,430 | +5,618 | +14.11% | 2024-12-31 |
| Tyche Wealth Partners Llc | $48.00 | 0.38% | 37,700 | +37,700 | New | 2025-03-31 |
| Hrt Financial Lp | $19.00 | 0.15% | 14,629 | +14,629 | New | 2024-12-31 |
| Goldman Sachs Group Inc | $13.00 | 0.1% | 10,274 | +10,274 | New | 2024-12-31 |
| Trinity Financial Advisors Llc | $13.00 | 0.1% | 10,000 | +10,000 | New | 2025-03-31 |
| Blackrock, Inc. | $12.00 | 0.09% | 9,126 | 0 | 0% | 2025-03-31 |
| Whittier Trust Co | $6.00 | 0.05% | 5,000 | +5,000 | New | 2025-03-31 |
| Tower Research Capital Llc (Trc) | $4.00 | 0.03% | 3,435 | +2,562 | +293.47% | 2024-12-31 |
| Pnc Financial Services Group, Inc. | $3.00 | 0.03% | 2,475 | +975 | +65% | 2024-12-31 |